Benjamin Alford

Reducing the Toxicity of Designer Aminoglycosides as Nonsense Mutation Readthrough Agents for Therapeutic Targets.

M. Roberge, A. Baradaran‐Heravi, Z. Gan, 2021, ACS medicinal chemistry letters.